PER percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-141

  1. 35,790 Posts.
    lightbulb Created with Sketch. 555
    that’s the thing with biotech, drug discovery & clinical trials ….

    you don’t have the answers and maybe its not the right place for your investment …

    dates have always been what they are (ironically very similar to akki’s calls he was lambasted for years on with these threads lol)

    preliminary data end of year FDA submissions and outcomes 2025 …

    if they want more & don’t granted accelerated approval then validity of the voucher comes into question
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.2¢ 1.3¢ 1.0¢ $277.9K 24.26M

Buyers (Bids)

No. Vol. Price($)
11 2273797 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 5066000 5
View Market Depth
Last trade - 16.14pm 26/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.